TIPARP and breast cancer: Consistent with these findings, we reported that injection of mice with murine EO771 breast cancer cells in which PARP7 was knocked out (Parp7KO) resulted in >80% reduced tumour growth in Parp7 deficient mice compared with injected wildtype (WT) EO771 cells in WT mice (32).